严禁使用人工智能等自动生成处方规定的实践挑战及应对策略
Practical challenges and coping strategies for prohibiting the automatic generation of prescription regulations such as artificial intelligence
章梦琪 1邓勇1
作者信息
- 1. 北京中医药大学人文学院 北京 102488
- 折叠
摘要
禁止人工智能代开处方规定(以下简称规定)在实践中面临诸多挑战,如注册医师数量难以满足互联网医疗需求、监督执法主体尚待明确、法律责任划分不清、监管强化和成本管控之间的博弈等.规定的出台具有学理和法律依据,对利益相关者,即卫生行政部门、互联网医疗机构和患者都产生了或将产生一定程度的影响,但总体来看利大于弊.因此在利益相关者理论视角下,对各利益相关方提出应对建议,以破解规定施行中的难题,实现互联网诊疗与实体机构诊疗服务最大限度的"同质".
Abstract
The provisions prohibiting artificial intelligence from prescribing on behalf of prescriptions(hereinaf-ter referred to as the"Provisions")face many challenges in practice,such as the difficulty of the number of regis-tered physicians to meet the needs of Internet medical treatment,the need to clarify the subject of supervision and law enforcement,the unclear division of legal responsibilities,and the game between regulatory strengthening and cost control.The promulgation of the regulations has a scientific and legal basis,and has or will have a certain de-gree of impact on stakeholders,i.e.health administrative agencies,Internet medical institutions and patients,but on the whole,the benefits outweigh the disadvantages.Therefore,from the perspective of stakeholder theory,sug-gestions are put forward for various stakeholders to solve the problems in the implementation of the regulations and achieve the maximum"homogeneity"between Internet diagnosis and treatment and physical institutions'diagnosis and treatment services.
关键词
人工智能/代开处方/利益相关者/应对策略Key words
Artificial intelligence/Prescribing on behalf of others/Stakeholders/Response strategies引用本文复制引用
出版年
2024
NETL
NSTL
万方数据